Literature DB >> 27495231

FGF9, activin and TGFβ promote testicular characteristics in an XX gonad organ culture model.

Sonja E Gustin1, Jessica M Stringer1, Kirsten Hogg1, Andrew H Sinclair2, Patrick S Western3.   

Abstract

Testis development is dependent on the key sex-determining factors SRY and SOX9, which activate the essential ligand FGF9. Although FGF9 plays a central role in testis development, it is unable to induce testis formation on its own. However, other growth factors, including activins and TGFβs, also present testis during testis formation. In this study, we investigated the potential of FGF9 combined with activin and TGFβ to induce testis development in cultured XX gonads. Our data demonstrated differing individual and combined abilities of FGF9, activin and TGFβ to promote supporting cell proliferation, Sertoli cell development and male germ line differentiation in cultured XX gonads. FGF9 promoted proliferation of supporting cells in XX foetal gonads at rates similar to those observed in vivo during testis cord formation in XY gonads but was insufficient to initiate testis development. However, when FGF9, activin and TGFβ were combined, aspects of testicular development were induced, including the expression of Sox9, morphological reorganisation of the gonad and deposition of laminin around germ cells. Enhancing β-catenin activity diminished the testis-promoting activities of the combined growth factors. The male promoting activity of FGF9 and the combined growth factors directly or indirectly extended to the germ line, in which a mixed phenotype was observed. FGF9 and the combined growth factors promoted male germ line development, including mitotic arrest, but expression of pluripotency genes was maintained, rather than being repressed. Together, our data provide evidence that combined signalling by FGF9, activin and TGFβ can induce testicular characteristics in XX gonads.
© 2016 Society for Reproduction and Fertility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27495231     DOI: 10.1530/REP-16-0293

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  5 in total

1.  Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2.

Authors:  Stefan Bagheri-Fam; Anthony D Bird; Liang Zhao; Janelle M Ryan; Meiyun Yong; Dagmar Wilhelm; Peter Koopman; Veraragavan P Eswarakumar; Vincent R Harley
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

2.  The Impact of Activin A on Fetal Gonocytes: Chronic Versus Acute Exposure Outcomes.

Authors:  Sarah C Moody; Penny A F Whiley; Patrick S Western; Kate L Loveland
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

3.  Reduced PRC2 function alters male germline epigenetic programming and paternal inheritance.

Authors:  Jessica M Stringer; Samuel C Forster; Zhipeng Qu; Lexie Prokopuk; Moira K O'Bryan; David K Gardner; Stefan J White; David Adelson; Patrick S Western
Journal:  BMC Biol       Date:  2018-09-20       Impact factor: 7.431

4.  Dysregulation of FGFR signalling by a selective inhibitor reduces germ cell survival in human fetal gonads of both sexes and alters the somatic niche in fetal testes.

Authors:  K Harpelunde Poulsen; J E Nielsen; H Frederiksen; C Melau; K Juul Hare; L Langhoff Thuesen; S Perlman; L Lundvall; R T Mitchell; A Juul; E Rajpert-De Meyts; A Jørgensen
Journal:  Hum Reprod       Date:  2019-11-01       Impact factor: 6.918

5.  An In Vitro Differentiation Protocol for Human Embryonic Bipotential Gonad and Testis Cell Development.

Authors:  Ingrid M Knarston; Svenja Pachernegg; Gorjana Robevska; Irene Ghobrial; Pei Xuan Er; Elizabeth Georges; Minoru Takasato; Alexander N Combes; Anne Jørgensen; Melissa H Little; Andrew H Sinclair; Katie L Ayers
Journal:  Stem Cell Reports       Date:  2020-11-19       Impact factor: 7.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.